CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 8 enrolled
Drug / intervention
Reprogramming dual chamber pacemakerdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02027909
NCT02027909N/ACompleted
CompareCT.gov

A Comparison of Rate Response Performance in Pacemaker Patients With an Indication of Sinus Node Dysfunction.

Arun Rao·observational·Posted Jan 6, 2014·Updated Apr 25, 2018

In Brief

An observational study evaluating Reprogramming dual chamber pacemaker for Sinus Node Dysfunction. Completed, enrolled 8 participants across 1 site.

Detailed Summary

Providing ideal rate response to patients should improve their quality of life and ability to execute activities of daily living. Medtronic pacemakers provide rate response pacing by utilizing dual zone programming to specify an "activities of daily living" (ADL) response rate and an "exertion" response rate. There is much data to support the target heart rate for an exercise response but the data to support the programming of the ADL rate is lacking.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSinus Node Dysfunction
CountriesUnited States
CollaboratorsMedtronic

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedJan 6, 2014
Enrollment StartNov 1, 2011
Primary CompletionApr 1, 2015
TodayJul 2, 2026
Enrollment to primary: 3.4 yearsPosted 12.5 years ago

Interventions

Reprogramming dual chamber pacemakerdevice

Reprogramming rate response feature in the Medtronic pacemaker to each arm with crossover